Literature DB >> 1689369

Characterization of monoclonal antibodies that distinguish simian immunodeficiency virus isolates from each other and from human immunodeficiency virus types 1 and 2.

S Sutjipto1, T Kodama, J Yee, A Gettie, M Jennings, R C Desrosiers, P A Marx.   

Abstract

Two monoclonal antibodies (MAbs) against p27 and one against p17 of simian immunodeficiency virus (SIV) from rhesus macaques were produced and characterized by reacting with disrupted, viral antigens on immunoblots. Human immunodeficiency virus type 1 (HIV-1), HIV-2 and SIV isolates from sooty mangabey, stump-tailed macaque, rhesus macaque and African green monkey (SIVSM, SIVStM, SIVMAC and SIVAGM) were used for comparative analysis. The p27 monoclonal antibodies HE3 and FA2 reacted with SIVMAC and SIVSM, but not with HIV-1, HIV-2, SIVStM and SIVAGM. The p17 monoclonal antibodies reacted with SIVMAC and SIVStM, but not HIV-1, HIV-2, SIVSM and SIVAGM. The differential reactivity of these monoclonal antibodies indicated that common conserved antigenic epitopes are shared between SIVMAC and SIVSM with respect to p27 MAbs and between SIVMAC and SIVStM with respect to p17. Since these MAbs reacted differently with the SIV isolates, they are useful reagents for comparative pathogenesis studies for differentiating SIV isolates.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689369     DOI: 10.1099/0022-1317-71-1-247

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  Spatial alterations between CD4(+) T follicular helper, B, and CD8(+) T cells during simian immunodeficiency virus infection: T/B cell homeostasis, activation, and potential mechanism for viral escape.

Authors:  Jung Joo Hong; Praveen K Amancha; Kenneth Rogers; Aftab A Ansari; Francois Villinger
Journal:  J Immunol       Date:  2012-03-02       Impact factor: 5.422

2.  Transfer of neuropathogenic simian immunodeficiency virus with naturally infected microglia.

Authors:  D Watry; T E Lane; M Streb; H S Fox
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

3.  Simian immunodeficiency virus infection of macaque bone marrow macrophages correlates with disease progression in vivo.

Authors:  M Kitagawa; A A Lackner; D J Martfeld; M B Gardner; S Dandekar
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

4.  Characterization of murine monoclonal antibodies directed against the core proteins of human immunodeficiency virus types 1 and 2.

Authors:  M Niedrig; J Hinkula; H P Harthus; M Bröker; L Hopp; G Pauli; B Wahren
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

5.  Localization of simian immunodeficiency virus in the central nervous system of rhesus monkeys.

Authors:  A A Lackner; M O Smith; R J Munn; D J Martfeld; M B Gardner; P A Marx; S Dandekar
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

6.  Identification of highly attenuated mutants of simian immunodeficiency virus.

Authors:  R C Desrosiers; J D Lifson; J S Gibbs; S C Czajak; A Y Howe; L O Arthur; R P Johnson
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  Method for detection of simian immunodeficiency virus neutralizing antibodies using a noncommercial antigen capture enzyme-linked immunosorbent assay.

Authors:  M J Welch; M E Thouless
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

8.  Identification of viral determinants of macrophage tropism for simian immunodeficiency virus SIVmac.

Authors:  B Banapour; M L Marthas; R A Ramos; B L Lohman; R E Unger; M B Gardner; N C Pedersen; P A Luciw
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

9.  Localization of SIV in the genital tract of chronically infected female rhesus macaques.

Authors:  C J Miller; P Vogel; N J Alexander; S Sutjipto; A G Hendrickx; P A Marx
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

10.  Progression to AIDS in the absence of a gene for vpr or vpx.

Authors:  J S Gibbs; A A Lackner; S M Lang; M A Simon; P K Sehgal; M D Daniel; R C Desrosiers
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.